Amy Coxon

2.2k total citations
20 papers, 1.6k citations indexed

About

Amy Coxon is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Amy Coxon has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Ophthalmology. Recurrent topics in Amy Coxon's work include Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (5 papers) and Cancer-related gene regulation (4 papers). Amy Coxon is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (5 papers) and Cancer-related gene regulation (4 papers). Amy Coxon collaborates with scholars based in United States, Ukraine and Malaysia. Amy Coxon's co-authors include Frederic J. Kaye, Gregory A. Otterson, Robert A. Kratzke, Samir N. Khleif, Takefumi Komiya, Ilan R. Kirsch, Akihito Kubo, Kevin O’Neil, F Kaye and Lizi Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and The EMBO Journal.

In The Last Decade

Amy Coxon

20 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Coxon United States 16 1.0k 851 449 199 178 20 1.6k
Nadem Soufir France 22 649 0.6× 877 1.0× 124 0.3× 323 1.6× 89 0.5× 47 1.7k
Z Stasková Czechia 10 943 0.9× 641 0.8× 220 0.5× 277 1.4× 205 1.2× 14 1.4k
Miki Hashimura Japan 23 396 0.4× 731 0.9× 151 0.3× 255 1.3× 128 0.7× 56 1.4k
Harry C. Hwang United States 26 892 0.9× 1.1k 1.3× 219 0.5× 391 2.0× 315 1.8× 37 2.6k
N R Lemoine United Kingdom 19 1.1k 1.1× 899 1.1× 400 0.9× 235 1.2× 175 1.0× 32 2.1k
Benjamin Alderete United States 9 303 0.3× 913 1.1× 42 0.1× 250 1.3× 135 0.8× 17 1.3k
Peter Scully United States 7 1.4k 1.3× 1.1k 1.3× 87 0.2× 266 1.3× 125 0.7× 8 2.0k
Sandra Salvi Italy 23 707 0.7× 473 0.6× 96 0.2× 201 1.0× 75 0.4× 44 1.5k
Nicolas Janin France 19 620 0.6× 818 1.0× 108 0.2× 314 1.6× 231 1.3× 40 1.5k
Claude Houdayer France 24 761 0.7× 920 1.1× 211 0.5× 271 1.4× 168 0.9× 66 1.9k

Countries citing papers authored by Amy Coxon

Since Specialization
Citations

This map shows the geographic impact of Amy Coxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Coxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Coxon more than expected).

Fields of papers citing papers by Amy Coxon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Coxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Coxon. The network helps show where Amy Coxon may publish in the future.

Co-authorship network of co-authors of Amy Coxon

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Coxon. A scholar is included among the top collaborators of Amy Coxon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Coxon. Amy Coxon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daily, Kenneth, Amy Coxon, Jonathan S. Williams, et al.. (2014). Assessment of Cancer Cell Line Representativeness Using Microarrays for Merkel Cell Carcinoma. Journal of Investigative Dermatology. 135(4). 1138–1146. 34 indexed citations
2.
Komiya, Takefumi, Amy Coxon, Yikyung Park, et al.. (2009). Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene. 29(11). 1672–1680. 39 indexed citations
3.
Kubo, Akihito, Takefumi Komiya, Amy Coxon, et al.. (2008). Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras. Cell Cycle. 7(15). 2384–2391. 5 indexed citations
4.
Komiya, Takefumi, et al.. (2006). Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene. 25(45). 6128–6132. 62 indexed citations
5.
Dussault, Isabelle, et al.. (2006). HGF- and c-Met-targeted drugs: Hopes, challenges and their future in cancer therapy. Drugs of the Future. 31(9). 819–819. 8 indexed citations
6.
Coxon, Amy, Ester Rozenblum, Yoon Soo Park, et al.. (2005). Mect1-Maml2 Fusion Oncogene Linked to the Aberrant Activation of Cyclic AMP/CREB Regulated Genes. Cancer Research. 65(16). 7137–7144. 107 indexed citations
7.
Tonon, Giovanni, Lizi Wu, Akihito Kubo, et al.. (2003). t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nature Genetics. 33(2). 208–213. 428 indexed citations
8.
Coxon, Amy. (2001). Euthanasia and Physician-Assisted Suicide: For and Against. 17(2). 125. 1 indexed citations
9.
Kubo, Akihito, et al.. (2000). Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Oncogene. 19(40). 4632–4639. 38 indexed citations
10.
Otterson, Gregory A., et al.. (1999). Temperature-Sensitive RB Mutations Linked to Incomplete Penetrance of Familial Retinoblastoma in 12 Families. The American Journal of Human Genetics. 65(4). 1040–1046. 29 indexed citations
11.
Coxon, Amy, Jerrold M. Ward, Joseph Geradts, et al.. (1998). RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene. 17(12). 1625–1628. 34 indexed citations
12.
Chen, Wei-Dong, Gregory A. Otterson, Stan Lipkowitz, et al.. (1997). Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14(10). 1243–1248. 69 indexed citations
13.
Otterson, Gregory A., Wei-Dong Chen, Amy Coxon, Samir N. Khleif, & Frederic J. Kaye. (1997). Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proceedings of the National Academy of Sciences. 94(22). 12036–12040. 77 indexed citations
14.
Otterson, Gregory A., Samir N. Khleif, Wei Chen, Amy Coxon, & F Kaye. (1995). CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.. PubMed. 11(6). 1211–6. 182 indexed citations
15.
Shimizu, Eiji, Amy Coxon, S. M. Steinberg, et al.. (1995). RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Lung Cancer. 12(1-2). 122–122. 98 indexed citations
16.
Otterson, Gregory A., et al.. (1995). Absence of p16(INK4) protein is restricted to the subset of lung cancer lines that retains wildtype RB. Lung Cancer. 12(3). 273–273. 278 indexed citations
17.
Kim, Young Whan, Gregory A. Otterson, Robert A. Kratzke, Amy Coxon, & Frederic J. Kaye. (1994). Differential Specificity for Binding of Retinoblastoma Binding Protein 2 to RB, pl07, and TATA-Binding Protein. Molecular and Cellular Biology. 14(11). 7256–7264. 3 indexed citations
18.
Otterson, Gregory A., et al.. (1994). Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.. Molecular and Cellular Biology. 14(11). 7256–7264. 41 indexed citations
19.
Otterson, Gregory A., Gregory C. Flynn, Robert A. Kratzke, et al.. (1994). Stch encodes the ‘ATPase core’ of a microsomal stress 70 protein.. The EMBO Journal. 13(5). 1216–1225. 46 indexed citations
20.
Kratzke, Robert A., Gregory A. Otterson, Annette Hogg, et al.. (1994). Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.. PubMed. 9(5). 1321–6. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadem Soufir Breakdown of academic impact, for papers by Z Stasková Breakdown of academic impact, for papers by Miki Hashimura Breakdown of academic impact, for papers by Harry C. Hwang Breakdown of academic impact, for papers by N R Lemoine Breakdown of academic impact, for papers by Benjamin Alderete Breakdown of academic impact, for papers by Peter Scully Breakdown of academic impact, for papers by Sandra Salvi Breakdown of academic impact, for papers by Nicolas Janin Breakdown of academic impact, for papers by Claude Houdayer
Rankless by CCL
2026